Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 12
Nordic study finds cancer mortality rates have sunk
By
Rebekah Moan
Mortality rates for prostate and breast cancers in the Nordic region have declined by between 22% in Finland for prostate cancer and 32% for breast cancer in Norway since the 1990s. The drop is not driven by changes in risk factors but rather by improvements in cancer detection and management, researchers have found.
August 23, 2017
EU OK's Bracco's SonoVue for urinary infection in kids
By
AuntMinnieEurope.com staff writers
Bracco Imaging announced that its SonoVue ultrasound contrast agent has obtained approval in the European Union (EU) for use in ultrasonography of the urinary tract for evaluating suspected or known vesicoureteral reflux in pediatric patients.
July 3, 2017
German team wins SNMMI Image of the Year award
By
Wayne Forrest
The U.S. Society of Nuclear Medicine and Molecular Imaging (SNMMI) on 14 June awarded its Image of the Year to German researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.
June 18, 2017
SNMMI Image of the Year awarded to German researchers
By
Wayne Forrest
DENVER - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) on Wednesday awarded its Image of the Year to researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.
June 18, 2017
Portuguese highlight rapid clinical progress of pelvic MRI
By
Philip Ward
When integrated with prior clinical evaluation and exclusion of organic disease, pelvic MRI can play an invaluable role in the diagnosis, therapeutic guidance, and follow-up of pelvic floor dysfunction disorders, according to Portuguese researchers.
April 23, 2017
Italians show CAD improves prostate biopsy targeting
By
Eric Barnes
An artificial intelligence-based computer-aided detection (CAD) system that analyzes prostate MR images for tumors improves the targeting of core biopsies for cancer diagnosis, according to Italian research presented at ECR 2017. With fine-tuning, the system could improve patient care.
April 10, 2017
Analogic to launch MR-ultrasound prostate biopsy software
By
AuntMinnieEurope.com staff writers
Analogic plans to launch new MR fusion prostate biopsy software for ultrasound at the European Association of Urology meeting in London.
March 23, 2017
New PET tracer advances prostate cancer detection
By
AuntMinnieEurope.com staff writers
Researchers have developed a new PET radiotracer designed to detect both early and advanced prostate cancer and help direct treatment, according to a study in the February issue of the
Journal of Nuclear Medicine
.
February 7, 2017
RCR applauds results of Lancet prostate study
By
AuntMinnieEurope.com staff writers
The U.K. Royal College of Radiologists (RCR) said the results of the Prostate MR Imaging Study (PROMIS), published last Thursday in the
Lancet
, will "lead to a paradigm shift in the way men with suspected prostate cancer are investigated."
January 23, 2017
MRI can help avoid unnecessary prostate cancer biopsies
By
Wayne Forrest
By first undergoing a multiparametric MRI scan, more than 25% of men with suspected prostate cancer could avoid a needle biopsy guided by transrectal ultrasound, according to a study published online January 19 in
Lancet
.
January 19, 2017
ESUR issues new MR guidelines on adnexal masses
By
Rebekah Moan
The European Society of Urogenital Radiology (ESUR) has updated its guidance on MRI of the sonographically indeterminate adnexal mass integrating functional techniques. One of the more significant changes concerns solid adnexal masses with low T2 signal, for which diffusion-weighted imaging (DWI) is recommended now.
October 26, 2016
Blue Earth PET radiotracer IDs prostate cancer recurrence
By
AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Blue Earth Diagnostics is highlighting results from a phase III clinical trial of its Axumin (fluciclovine F-18) PET radiopharmaceutical agent indicating a 68% detection rate for prostate cancer recurrence.
October 23, 2016
Previous Page
Page 12 of 22
Next Page